PIONEERS IN RAT BIRTH CONTROL®

SenesTech, Inc. has developed proprietary technologies for managing animal pest populations through fertility control.

About SenesTech

We are committed to improving the health of the world by humanely managing animal pest populations through fertility control. We are experts in fertility control to manage animal pest populations.

We invented ContraPest®, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum-risk contraceptive currently offered for rats. ContraPest® and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management.

We strive for clean cities, efficient businesses and happy households – with products designed to be humane, effective and sustainable.

 

MISSION & VISION

We are committed to improving the health of our world by humanely managing animal populations through fertility control. Our vision is to provide responsible and innovative solutions that positively impact our environment and provide sustainable benefits to both the world and our company.

OUR PRODUCTS

Our products are changing the game of pest management. Evolve™ soft bait and ContraPest® liquid Rat Birth Control® interfere with the reproductive mechanisms in both male and female rats. Working in tandem with traditional pest control methods as part of a complete Integrated Pest Management (IPM) strategy, our products help target the source of an infestation for long-term success.

Shop Now

Press Releases
Apr 2, 2024

SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced that its Chief Executive Officer, Joel Fruendt, will be participating in the...

Mar 26, 2024

SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces a signed distribution agreement with Wilco...

Mar 5, 2024

SenesTech, Inc. (NASDAQ: SNES) today announced that the Company will be participating in the Emerging Growth Conference on March 6, 2024. Management will deliver a webcasted presentation and...

View All

Multimedia

Senestech: CEO Joel Fruendt Answers Frequently Asked Investor Questions

To view more videos from this series click here.

Senestech: Diving into the Recent News Around the Warrant Inducement

To view more videos from this series click here.

Senestech: Discussing the Product Lineup & More with CEO Joel Fruendt

To view more videos from this series click here.

Contact

COMPANY CONTACT
Tom Chesterman
Chief Financial Officer
marketing@senestech.com
928-779-4143 x825

INVESTOR RELATIONS CONTACT
Lytham Partners
senestech@lythampartners.com
602-889-9700